The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 14, 2020
Filed:
Apr. 07, 2017
Applicant:
Boehringer Ingelheim International Gmbh, Ingelheim am Rhein, DE;
Inventors:
Doris Riether, Biberach an der Riss, DE;
Marco Ferrara, Sam Donato Milanese, IT;
Niklas Heine, Biberach an der Riss, DE;
Uta Lessel, Maselheim, DE;
Janet Rachel Nicholson, Oberhoefen, DE;
Anton Pekcec, Munich, DE;
Stefan Scheuerer, Warthausen, DE;
Assignee:
Boehringer Ingelheim International GmbH, Ingelheim am Rhein, DE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 403/12 (2006.01); C07D 401/14 (2006.01); C07D 401/12 (2006.01); C07D 417/12 (2006.01); A61K 51/00 (2006.01);
U.S. Cl.
CPC ...
C07D 403/12 (2013.01); A61K 51/00 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 417/12 (2013.01);
Abstract
The present invention relates to novel N-[(Pyrimidinylamino)propanyl]- and N-[(Pyridinylamino)propanyl]arylcarboxamide derivatives, processes for their preparation, pharmaceutical compositions containing them and their use in therapy, particularly in the treatment or prevention of conditions having an association with the orexin sub-type 1 receptor.